Sana Biotechnology Inc vs Atlassian Corporation PLC — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Atlassian Corporation PLC trades at $90.5 (market cap $23.67B). The key difference: Atlassian Corporation PLC is far larger — about 27.1× Sana Biotechnology Inc's market cap. Which is the better fit depends on your goals.
| SANA | TEAM | |
|---|---|---|
Market Cap | $873.84M | $23.67B |
Sector | Health | Technology |
52-Week High | $5.92 | $203.00 |
52-Week Low | $2.68 | $57.15 |
Enterprise Value | $848.03M | $23.78B |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →